Uvaridacols E-H, highly oxygenated antiausterity agents from Uvaria dac
Suresh Awale1, Jun-ya Ueda, Sirivan Athikomkulchai
1Frontier Research Core for Life Sciences, University of Toyama , 2630 Sugitani, Toyama 930-0194, Japan.
Journal of Natural Products
|October 25, 2012
Summary
Four new compounds, uvaridacols E-H, were isolated from Uvaria dac stems. Some compounds showed selective toxicity against pancreatic cancer cells under nutrient deprivation.
Area of Science:
- Natural Products Chemistry
- Medicinal Chemistry
- Organic Chemistry
Background:
- Uvaria dac is a plant species with potential medicinal properties.
- The discovery of novel bioactive compounds from natural sources is crucial for drug development.
Purpose of the Study:
- To isolate and characterize new chemical constituents from the stems of Uvaria dac.
- To evaluate the cytotoxic activity of the isolated compounds against human pancreatic cancer cells.
Main Methods:
- Phytochemical investigation of Uvaria dac stems.
- Structure elucidation using Nuclear Magnetic Resonance (NMR) and Circular Dichroism (CD) spectroscopy.
- In vitro cytotoxicity assays against PANC-1 cells under nutrient-deprived and nutrient-rich conditions.
Main Results:
- Four new highly oxygenated cyclohexene derivatives, named uvaridacols E-H (1-4), were identified.
- Uvaridacols E (1), F (2), and H (4) exhibited weak preferential cytotoxicity against PANC-1 cells.
- The observed cytotoxicity was specific to nutrition-deprived conditions, with no toxicity in normal nutrient-rich conditions.
Conclusions:
- The chemical investigation led to the discovery of novel cyclohexene derivatives from Uvaria dac.
- Uvaridacols E, F, and H demonstrate potential as selective anticancer agents for pancreatic cancer, particularly under specific metabolic conditions.
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:31Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...